Capricor Therapeutics, Inc.
CAPR$7.59+0.80% 1D
$2.9652-week range$40.37
Updated . Prices are snapshots and may be delayed.
Capricor Therapeutics, Inc. price chart
−16.78% over 7D
$9.23
$7.52
Nov 21
Nov 22
AI Outlook for Capricor Therapeutics, Inc.
Bearish posture- Long-term trend-61.2% vs 200-day average
- Medium-term trend-5.4% vs 50-day average
- Averages50-day below 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Capricor Therapeutics, Inc. performance
1D
+0.8%
7D
−20.4%
30D
+29.1%
90D
+20.7%
1Y
+63.6%
About Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. is a biotechnology company based in the United States, listed on NASDAQ since 2002 (ticker CAPR).
Capricor Therapeutics, Inc. market data
What is the price of Capricor Therapeutics, Inc. today?
Capricor Therapeutics, Inc. (CAPR) is at $7.59, +0.80% on the day.
What is the 52-week range of Capricor Therapeutics, Inc.?
Over the past year Capricor Therapeutics, Inc. has traded between $2.96 and $40.37. It is currently 12% of the way up that range.
Similar stocks
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
$2.45−9.9%
VIVS
VivoSim Labs, Inc. Common Stock
$0.2608−10.5%
LABT
Lakewood-Amedex Biotherapeutics Inc
$0.2449+15.0%
PURR
Hyperliquid Strategies Inc.
$7.48−11.0%
SVRA
Savara Inc.
$4.26−18.2%
CYPH
Cypherpunk Technologies Inc.
$1.41−18.0%
SLS
SELLAS Life Sciences Group, Inc.
$13.66−8.1%
NTLA
Intellia Therapeutics, Inc.
$10.00+5.0%
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.








